BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dai Q, Luo H, Li XP, Huang J, Zhou TJ, Yang ZH. XRCC1 and ERCC1 polymorphisms are related to susceptibility and survival of colorectal cancer in the Chinese population. Mutagenesis. 2015;30:441-449. [PMID: 25690281 DOI: 10.1093/mutage/geu088] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Xue P, Zhang G, Zhang H, Cui S, Zhang L, Yu T, Xiao M, Li L, Lu X. A miR-15a related polymorphism affects NSCLC prognosis via altering ERCC1 repair to platinum-based chemotherapy. J Cell Mol Med 2022. [PMID: 36181289 DOI: 10.1111/jcmm.17566] [Reference Citation Analysis]
2 Xue S, Shen W, Cai J, Jia J, Zhao D, Zhang S, Zhao X, Ma N, Wang W, Wang B, Zhang X, Liu X. Association between rs735482 polymorphism and risk of cancer: A meta-analysis of 10 case-control studies. Medicine (Baltimore) 2022;101:e29318. [PMID: 35905230 DOI: 10.1097/MD.0000000000029318] [Reference Citation Analysis]
3 Vasistha A, Kothari R, Mishra A, De Andrés F, LLerena A, Nair S. Current Insights into Interethnic Variability in Testicular Cancers: Population Pharmacogenetics, Clinical Trials, Genetic Basis of Chemotherapy- Induced Toxicities and Molecular Signal Transduction. Curr Top Med Chem 2020;20:1824-38. [PMID: 32552648 DOI: 10.2174/1568026620666200618112205] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Hulshof EC, Lim L, de Hingh IHJT, Gelderblom H, Guchelaar HJ, Deenen MJ. Genetic Variants in DNA Repair Pathways as Potential Biomarkers in Predicting Treatment Outcome of Intraperitoneal Chemotherapy in Patients With Colorectal Peritoneal Metastasis: A Systematic Review. Front Pharmacol 2020;11:577968. [PMID: 33117169 DOI: 10.3389/fphar.2020.577968] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
5 Wang C, Gan N, Liu P, Chen H, Li Y, Li X. Expression and Genetic Polymorphisms of ERCC1 in Chinese Han Patients with Oral Squamous Cell Carcinoma. Biomed Res Int 2020;2020:1207809. [PMID: 33029487 DOI: 10.1155/2020/1207809] [Reference Citation Analysis]
6 Wang X, Zhang AQ, Gu W, Wen DL, Lu HX, Yang JH, Wang X, Deng J, Zhang HQ, Du DY, Zhang LY, Zeng L, Jiang JX. Clinical relevance of single nucleotide polymorphisms in the CXCL1 and CXCL12 genes in patients with major trauma. J Trauma Acute Care Surg 2019;86:440-7. [PMID: 30489503 DOI: 10.1097/TA.0000000000002141] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Salimzadeh H, Lindskog EB, Gustavsson B, Wettergren Y, Ljungman D. Association of DNA repair gene variants with colorectal cancer: risk, toxicity, and survival. BMC Cancer 2020;20:409. [PMID: 32397974 DOI: 10.1186/s12885-020-06924-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
8 Li YK, Xu Q, Sun LP, Gong YH, Jing JJ, Xing CZ, Yuan Y. Nucleotide excision repair pathway gene polymorphisms are associated with risk and prognosis of colorectal cancer. World J Gastroenterol 2020; 26(3): 307-323 [PMID: 31988591 DOI: 10.3748/wjg.v26.i3.307] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
9 Ezzeldin N, El-lebedy D, Mohammed A. Gene-environment and gene-gene interactions between CHRNA3 rs1051730, XRCC1 rs25487, and ERCC1 rs735482 variants highly elevate the risk of lung cancer. Egypt J Med Hum Genet 2019;20:23. [DOI: 10.1186/s43042-019-0034-1] [Reference Citation Analysis]
10 Gan L, Hu C, Deng Z, Lu H, Sun J, Peng G, Jiang J, Zeng L, Deng J. Rs1982809 is a functional biomarker for the prognosis of severe post-traumatic sepsis and MODs. Exp Biol Med (Maywood) 2019;244:1438-45. [PMID: 31594403 DOI: 10.1177/1535370219880490] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
11 Huang YL, Wu JR, Fang M, Zhao HL, Liu ZM, Ye J, Huang LS, Zhu B. The role of ERCC1 and AFP gene polymorphism in hepatocellular carcinoma. Medicine (Baltimore) 2019;98:e15090. [PMID: 30946366 DOI: 10.1097/MD.0000000000015090] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
12 Anoushirvani AA, Aghabozorgi R, Ahmadi A, Arjomandzadegan M, Khalili S, Sahraei M, Fereydouni T, Khademi Z. The Relationship Between rs3212986C>A Polymorphism and Tumor Stage in Lung Cancer Patients. Cureus 2019;11:e4423. [PMID: 31245210 DOI: 10.7759/cureus.4423] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
13 Liu J, Zheng B, Li Y, Yuan Y, Xing C. Genetic Polymorphisms of DNA Repair Pathways in Sporadic Colorectal Carcinogenesis. J Cancer 2019;10:1417-33. [PMID: 31031852 DOI: 10.7150/jca.28406] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
14 Yu T, Xue P, Cui S, Zhang L, Zhang G, Xiao M, Zheng X, Zhang Q, Cai Y, Jin C, Yang J, Wu S, Lu X. Rs3212986 polymorphism, a possible biomarker to predict smoking-related lung cancer, alters DNA repair capacity via regulating ERCC1 expression. Cancer Med 2018;7:6317-30. [PMID: 30453383 DOI: 10.1002/cam4.1842] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
15 Mei PJ, Bai J, Miao FA, Li ZL, Chen C, Zheng JN, Fan YC. Relationship between expression of XRCC1 and tumor proliferation, migration, invasion, and angiogenesis in glioma. Invest New Drugs 2019;37:646-57. [PMID: 30328556 DOI: 10.1007/s10637-018-0667-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
16 Noureddini M, Mobasseri N, Karimian M, Behjati M, Nikzad H. Arg399Gln substitution in XRCC1 as a prognostic and predictive biomarker for prostate cancer: Evidence from 8662 subjects and a structural analysis. J Gene Med 2018;20:e3053. [DOI: 10.1002/jgm.3053] [Cited by in Crossref: 9] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
17 Hu LB, Chen Y, Meng XD, Yu P, He X, Li J. Nucleotide Excision Repair Factor XPC Ameliorates Prognosis by Increasing the Susceptibility of Human Colorectal Cancer to Chemotherapy and Ionizing Radiation. Front Oncol 2018;8:290. [PMID: 30109214 DOI: 10.3389/fonc.2018.00290] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
18 Huang MY, Huang JJ, Huang CM, Lin CH, Tsai HL, Huang CW, Chai CY, Lin CY, Wang JY. Relationship Between Expression of Proteins ERCC1, ERCC2, and XRCC1 and Clinical Outcomes in Patients with Rectal Cancer Treated with FOLFOX-Based Preoperative Chemoradiotherapy. World J Surg 2017;41:2884-97. [PMID: 28608017 DOI: 10.1007/s00268-017-4070-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
19 Zhang Q, Zheng X, Li X, Sun D, Xue P, Zhang G, Xiao M, Cai Y, Jin C, Yang J, Wu S, Lu X. The polymorphisms of miRNA-binding site in MLH3 and ERCC1 were linked to the risk of colorectal cancer in a case-control study. Cancer Med 2018;7:1264-74. [PMID: 29516665 DOI: 10.1002/cam4.1319] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
20 Lee KC, Lin CT, Chang SF, Chen CN, Liu JL, Huang WS. Effect of AICAR and 5-Fluorouracil on X-ray Repair, Cross-Complementing Group 1 Expression, and Consequent Cytotoxicity Regulation in Human HCT-116 Colorectal Cancer Cells. Int J Mol Sci 2017;18:E2363. [PMID: 29117108 DOI: 10.3390/ijms18112363] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
21 Liu LB, Liu T, Xin FZ. Correlations of ICAM-1 gene polymorphisms with susceptibility and multidrug resistance in colorectal cancer in a Chinese population. Medicine (Baltimore) 2017;96:e7481. [PMID: 28816939 DOI: 10.1097/MD.0000000000007481] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
22 Fouad H, Sabry D, Morsi H, Shehab H, Abuzaid NF. XRCC1 Gene Polymorphisms and miR-21 Expression in Patients with Colorectal Carcinoma. Eurasian J Med 2017;49:132-6. [PMID: 28638257 DOI: 10.5152/eurasianjmed.2017.17021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
23 Kap EJ, Popanda O, Chang-claude J. Nucleotide excision repair and response and survival to chemotherapy in colorectal cancer patients. Pharmacogenomics 2016;17:755-94. [DOI: 10.2217/pgs-2015-0017] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
24 Dai Q, Wei HL, Huang J, Zhou TJ, Chai L, Yang ZH. KRAS polymorphisms are associated with survival of CRC in Chinese population. Tumour Biol 2016;37:4727-34. [PMID: 26515332 DOI: 10.1007/s13277-015-4314-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]